Cellectis (CLLS) Other financing activities (2020 - 2023)

Cellectis' Other financing activities history runs 4 years deep, the most recent figure standing at $1.3 million for Q2 2023.

• On a quarterly basis, Other financing activities rose 417.16% year-over-year to $1.3 million in Q2 2023; TTM through Sep 2023 was $478000.0, a 94.58% decrease from a year earlier, with the FY2015 full-year figure at $240.1 million, up 202.63% from the prior year.
• Other financing activities climbed to $1.3 million in Q2 2023 per CLLS's latest filing, from $506000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $11.8 million in Q1 2021 and bottomed at -$1.3 million in Q3 2022.
• The 4-year median for Other financing activities is $269000.0 (2020), against an average of $2.8 million.
• Across the five-year window, Other financing activities plunged 1397.7% in 2022 and jumped 417.16% in 2023, its largest moves.
• Year by year, Other financing activities stood at $32000.0 in 2020, then sank by 371.88% to -$87000.0 in 2021, then plunged by 1397.7% to -$1.3 million in 2022, then surged by 197.85% to $1.3 million in 2023.
• Per Business Quant, the three latest CLLS Other financing activities figures stand at $1.3 million (Q2 2023), $506000.0 (Q1 2023), and -$1.3 million (Q3 2022).